Skip to content
HealthTech Series B Founded 2004

XeThru

Xethru, part of Novelda is an advanced sensor technology for detecting the presence and monitor breathing without any contact. Novelda is a developer and manufacturer of adaptive smart sensors. XeThru technology uses radio waves, rather than infrared, ultrasound or light, allowing these modules to see through a variety of objects including lightweight building materials, duvets, and blankets to provide non-contact…

📍 Oslo, Norway · Disease Self Management,

Funding snapshot

Last roundSeries B
Amount$15M
Date4 February 2019
Total raised$27M
Team size42

About

Xethru, part of Novelda is an advanced sensor technology for detecting the presence and monitor breathing without any contact. Novelda is a developer and manufacturer of adaptive smart sensors. XeThru technology uses radio waves, rather than infrared, ultrasound or light, allowing these modules to see through a variety of objects including lightweight building materials, duvets, and blankets to provide non-contact sensing at a range of up to several meters. The company operates in the Disease Self Management sector with additional focus on Wearable Technology and Wearable Technology. Its business model centers on Respiratory. Founded in 2004, headquartered in Oslo, Norway. The company has raised $27.0M at the Series B stage. Backed by investors including Investinor, Alliance Venture.

Business model

Wearable Technology > Health and Wellness Devices > Respiratory,

Disease Self Management > Body Health Parameters > Monitoring > Body Vitals > Device,

Sensors > Generic Sensor Developers > Biological > Body Vitals > Wireless

Institutional investors

Investinor Alliance Venture

Latest coverage

No articles yet.

Raising like XeThru?

Analyze your pitch deck before your next raise.

Analyze My Deck →